Overview
The purpose of the study is to evaluate the safety and tolerability of ENC-201-CED in a subcutaneous space in patients with Type I diabetes.
Eligibility
Inclusion Criteria:
- Candidates must satisfy site's eligibility for standard of care islet infusion.
Exclusion Criteria:
- Candidates are excluded based on the site's criteria for standard of care islet infusion.